Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia

Pediatric Blood and Cancer

Volumn 60, Issue 1, 2013, Pages 116-120

  Inagaki, Jiro ^a   Fukano, Reiji ^a   Nishikawa, Takuro ^a   Nakashima, Kentaro ^a   Sawa, Daisuke ^a   Ito, Nobuhiro ^a   Okamura, Jun ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Immunological intervention; JMML; Mixed chimerism; Stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER GROWTH; CANCER SURVIVOR; CHILD; CHIMERA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DONOR LYMPHOCYTE INFUSION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENGRAFTMENT; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE;

CHILD, PRESCHOOL; CHIMERISM; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; LYMPHOCYTE TRANSFUSION; MALE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84870232539     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24259     Document Type: Article

References (21)

1. Arico M, Biondi A, Pui CH. Juvenile myelomonocytic leukemia. Blood 1997; 90: 479-488.
2. Niemeyer CM, Kratz CP. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: Molecular classification and treatment options. Br J Haematol 2008; 140: 610-624.
3. Koike K, Matsuda K. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. Br J Haematol 2008; 141: 567-575.
4. Locatelli F, Nollke P, Zecca M, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): Results of the EWOG-MDS/EBMT trial. Blood 2005; 105: 410-419.
5. Manabe A, Okamura J, Yumura-Yagi K, et al. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the international JMML Working Group. Leukemia 2002; 16: 645-649.
6. Yusuf U, Frangoul HA, Gooley TA, et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: The Seattle experience. Bone Marrow Transplant 2004; 33: 805-814.
7. Korthof ET, Snijder PP, de Graaff AA, et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: A single center experience of 23 patients. Bone Marrow Transplant 2005; 35: 455-461.
8. Smith FO, King R, Nelson G, et al. Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. Br J Haematol 2002; 116: 716-724.
9. MacMillan ML, Davies SM, Orchard PJ, et al. Haematopoietic cell transplantation in children with juvenile myelomonocytic leukaemia. Br J Haematol 1998; 103: 552-558.
10. Orchard PJ, Miller JS, McGlennen R, et al. Graft-versus-leukemia is sufficient to induce remission in juvenile myelomonocytic leukemia. Bone Marrow Transplant 1998; 22: 201-203.
11. Matthes-Martin S, Mann G, Peters C, et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: A single centre experience and review of the literature. Bone Marrow Transplant 2000; 26: 377-382.
12. Pulsipher MA, Adams RH, Asch J, et al. Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: Evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML. Bone Marrow Transplant 2004; 33: 113-115.
13. Tanoshima R, Goto H, Yanagimachi M, et al. Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation. Pediatr Blood Cancer 2008; 50: 665-667.
14. Yoshimi A, Niemeyer CM, Bohmer V, et al. Chimerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia. Br J Haematol 2005; 129: 542-549.
15. Yoshimi A, Bader P, Matthes-Martin S, et al. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia 2005; 19: 971-977.
16. Niemeyer CM, Fenu S, Hasle H, et al. Differentiating juvenile myelomonocytic leukaemia from infectious disease. Blood 1998; 91: 365-367.
17. Kreyenberg H, Hölle W, Möhrle S, et al. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: The Tuebingen experience. Leukemia 2003; 17: 237-240.
18. Kröger N. Approaches to relapse after allogeneic stem cell transplantation. Curr Opin Oncol 2011; 23: 203-208.
19. Muñoz A, Badell I, Olivé T, et al. Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: long-term results of a multicenter study of the Spanish Working Party for Bone Marrow Transplantation in Children (GETMON). Haematologica 2002; 87: 331-332.
20. Chang YH, Jou ST, Lin DT, et al. Second allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukaemia: case report and literature review. J Pediatr Hematol Oncol 2004; 26: 190-193.
21. Yoshimi A, Mohamed M, Bierings M, et al. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukaemia. Leukemia 2007; 21: 556-560.